Francesca B.
- Country
- Italy
- Department
- Nephrology
Research Overview
- Safety Evaluation of Long-term Finerenone with ACE Inhibitor or Angiotensin Receptor Blocker in Pediatric Chronic Kidney Disease with Proteinuria
- Evaluation of Finerenone in Combination with ACEI or ARB for Proteinuria and Chronic Kidney Disease in Pediatric Patients: A Randomized, Double-Blind, Placebo-Controlled Trial
- A Phase 3, Open-Label, Single-arm, Multicenter Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Activity, and Safety of Ravulizumab Administered Subcutaneously in Pediatric Participants (2 to < 18 years of age) with Paroxysmal Nocturnal Hemoglobinuria (PNH) or Atypical Hemolytic Uremic Syndrome (aHUS)
Data & Insights
Has run more than one trial at 66 of 68 partner sites.
Specializations
Pediatric Hematological Disorders
The investigator specializes in treating rare blood disorders in children, with particular focus on Paroxysmal Nocturnal Hemoglobinuria (PNH) and Atypical Hemolytic Uremic Syndrome (aHUS).
- Blood disorder management
- Complement-mediated diseases
- Pediatric hematology therapy
Actively involved in evaluating innovative therapeutic approaches for rare hematological conditions in young patients.
Pediatric Nephrology
Focuses on treating children and young adults with chronic kidney disease and associated conditions, particularly proteinuria.
- Renal disorder management
- Proteinuria treatment
- Long-term kidney care
Explores therapeutic interventions for pediatric patients with kidney disorders using targeted treatment approaches.
Combined Therapeutic Approaches
Specializes in investigating combination therapies involving ACE inhibitors and angiotensin receptor blockers for pediatric patients.
- Multi-drug therapeutic strategies
- Pediatric drug safety
- Treatment optimization
Dedicated to developing effective treatment protocols for complex pediatric conditions requiring multiple therapeutic agents.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.